Emcure Pharmaceuticals lists with 31% premium on the BSE
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Emcure Pharmaceuticals has debuted at Rs 1325.05 on the BSE, up by 317.05 points or 31.45% from its issue price of Rs 1008.00.
The scrip is currently trading at Rs 1345.85, up by 337.85 points or 33.52% from its issue price.
It has touched a high and low of Rs 1384.00 and Rs 1325.05 respectively. So far 7.88 lakh shares were traded on the counter.
The offering, which was open for subscription between July 3, 2024 and July 5, 2024 was subscribed 67.87 times. The issue price was fixed at Rs 1008.00 per share i.e. at upper end of price band of Rs 960-1,008 apiece.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
